Showing results (121-130 of 188) with videos related to
Sort By:
Pageof 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Phase I and pharmacokinetic study of 24-hour infusion 5-fluorouracil and leucovorin in patients with organ dysfunctionG F Fleming, R L Schilsky, L P Schumm, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patientsA B Benson, O I Olopade, M J Ratain, et al.Cancer Research|March 1, 1989
Plasma pharmacokinetics of high-dose oral melphalan in patients treated with trialkylator chemotherapy and autologous bone marrow reinfusionK E Choi, M J Ratain, S F Williams, et al.Journal of the National Cancer Institute|January 15, 1992
Phase I-II trial of erythropoietin in the treatment of cisplatin-associated anemiaC B Miller, L C Platanias, S R Mills, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1988
Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variablesM J Ratain, H M Golomb, J W Vardiman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Human plasma pharmacokinetics of thiotepa following administration of high-dose thiotepa and cyclophosphamideS P Ackland, K E Choi, M J Ratain, et al.Cancer Chemotherapy and Pharmacology|January 1, 1991
Five-day infusion of fluorodeoxyuridine with high-dose oral leucovorin: a phase I studyE E Vokes, J W Raschko, N J Vogelzang, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Interleukin-2 fusion protein: an investigational therapy for interleukin-2 receptor expressing malignanciesJ Nichols, F Foss, T M Kuzel, et al.Clinical Pharmacology and Therapeutics|June 4, 2016
Genomewide Association Studies in Pharmacogenomics: Meeting Report of the NIH Pharmacogenomics Research Network-RIKEN (PGRN-RIKEN) CollaborationS W Yee, Y Momozawa, Y Kamatani, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995
Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agentE Gupta, O I Olopade, M J Ratain, et al.Pageof 19